Zydus gets final nod from USFDA for anti-bacterial drug
Zydus Cadila has received final approval from the USFDA to market Doxycycline Hyclate capsules USP, antibiotic used for treating bacterial infections.02-06-2018
Zydus gets final nod from USFDA for anti-bacterial drug
Zydus Cadila has received final approval from the USFDA to market Doxycycline Hyclate capsules USP, antibiotic used for treating bacterial infections.Board Meeting-Outcome of Board Meeting
Declaration in respect of Audit Report with an unmodified opinion for the Financial Year ended on March 31, 2018Corporate Action-Board approves Dividend
We hereby inform that the Company shall make the payment of dividend of Rs. 8/- (80%) on 39072089 Equity Shares of Re. 10/- each on or after August 8, 2018 subject to the approval of the same by the shareholders at the ensuing 24th Annual General Meeting scheduled to be held on August 3, 2018.Board Meeting-Outcome of Board Meeting
In compliance with Regulation 42[5] of the SEBI [Listing Obligations and Disclosure Requirements] Regulations, 2015, we inform that the Register of Members and Share Transfer Books shall be closed from Friday July 20, 2018 to Friday, August 3, 2018 [both days inclusive]. The Annual General Meeting of the members of the Company will be held on Friday, August 3, 2018.Option To Submit Consolidated Financial Results
The Board of Directors at the meeting held today i.e. May 24, 2018 decided to publish only consolidated financial results in the newspapers for the financial year 2018-2019. In view of it, as required under Regulation No. 33[3] of the SEBI [Listing Obligations and Disclosure Requirements] Regulations, 2015, we hereby inform that the Company shall publish only consolidated financial results in the newspapers for the financial year 2018-2019.Board recommends Final Dividend (AGM on August 03, 2018)
Zydus Wellness Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 24, 2018, have recommended final dividend of Rs.8/- (80%) per equity share of Rs.10/- each, subject to approval of the shareholders at the ensuing Annual General Meeting scheduled to be held on August 03, 2018.Intimation Of Book Closure Pursuant To Regulation 42 Of The Securities & Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Pursuant to regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, the Register of Member and Share Transfer Books of the Company will remain closed from July 20, 2018 to August 3, 2018 (both days inclusive) for taking record of the Members of the Company for the purpose of declaration of dividend.Board Meeting-Outcome of Board Meeting
The Board of Directors at their meeting held today have recommended final dividend of Rs. 8/- ( 80%) per equity share of Re. 10/- each, subject to approval of the shareholders at the ensuing Annual General Meeting scheduled to be held on August 3, 2018.Audited Financial Results For The Quarter And Year Ended On March 31, 2018.
Please find attached herewith the audited financial results for the quarter / year ended on March 31, 2018, reviewed by the Audit Committee and taken on record by the Board of Directors today i.e. May 24, 2018 pursuant to Regulation No. 33[2][a] of the SEBI [Listing Obligations and Disclosure Requirements] Regulations, 2015.